In the context of the pandemic, negative implications for mental health have increased considerably, as well as the existing associations of psychotropics in this period to combat the new coronavirus. In view of this, the present integrative review aimed to verify the health impact of covid-19 infection in patients with mental disorders who use psychotropics. As a result, the co-administration of these drugs represented a great risk at the systemic level, and can be lethal in certain cases. Thus, careful evaluations must be taken in order to implement an effective intervention that meets the needs of patients, always considering the risks of these drug associations.
Previous Article in event
Next Article in event
INFLUENCE OF INTESTINAL INFLAMMATORY DISEASES ON GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH COVID-19Next Article in session
RISKS ASSOCIATED WITH THE USE OF PSYCHOTROPICS IN PATIENTS DIAGNOSED WITH COVID-19
Published: 15 September 2021 by MDPI in The 1st International Electronic Conference on Clinical Medicine session Infectious Diseases
Keywords: Covid-19; mental disorders; medicines; drug interactions.